These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23051561)

  • 21. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clonal analysis of the meningococcal populations from invasive disease and healthy carriers isolated in the Czech Republic in 1971-2014 (May)].
    Jandová Z; Musílek M; Vacková Z; Kozáková J; Křížová P
    Epidemiol Mikrobiol Imunol; 2015 Sep; 64(3):147-52. PubMed ID: 26448302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic characteristics of serogroup A meningococci circulating in China, 1956-2005.
    Zhang X; Shao Z; Zhu Y; Xu L; Xu X; Mayer LW; Xu J; Jin Q
    Clin Microbiol Infect; 2008 Jun; 14(6):555-61. PubMed ID: 18373693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease.
    Tsang RSW; Ahmad T; Tyler S; Lefebvre B; Deeks SL; Gilca R; Hoang L; Tyrrell G; Van Caeseele P; Van Domselaar G; Jamieson FB
    Int J Infect Dis; 2018 Apr; 69():55-62. PubMed ID: 29414677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland.
    Waśko I; Hong E; De Paola R; Stella M; Moschioni M; Taha MK; Skoczyńska A
    Vaccine; 2016 Jan; 34(4):510-515. PubMed ID: 26686998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population snapshot of invasive serogroup B meningococci in South Africa from 2005 to 2008.
    du Plessis M; Moodley C; Mothibeli KM; Fali A; Klugman KP; von Gottberg A;
    J Clin Microbiol; 2012 Aug; 50(8):2577-84. PubMed ID: 22593593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003.
    Law DK; Stoltz J; Henderson AM; Tsang RS
    Can J Microbiol; 2005 Jul; 51(7):523-30. PubMed ID: 16175200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic.
    Dyet KH; Martin DR
    J Clin Microbiol; 2005 Feb; 43(2):838-42. PubMed ID: 15695689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).
    Law DK; Lorange M; Ringuette L; Dion R; Giguère M; Henderson AM; Stoltz J; Zollinger WD; De Wals P; Tsang RS
    J Clin Microbiol; 2006 Aug; 44(8):2743-9. PubMed ID: 16891487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal characteristics of invasive Neisseria meningitidis following initiation of an A + C vaccination program in China, 2005-2012.
    Zhou H; Shan X; Sun X; Xu L; Gao Y; Li M; Shao Z
    J Infect; 2015 Jan; 70(1):37-43. PubMed ID: 25107632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of factor H Binding Protein sub-variants among Neisseria meningitidis in China.
    Shi F; Zhang A; Zhu B; Gao Y; Xu L; Li Y; Yin Z; Li J; Xie N; Shao Z
    Vaccine; 2017 Apr; 35(18):2343-2350. PubMed ID: 28351732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Oropharyngeal Carriage Isolates of Neisseria meningitidis in Healthy Korean Adolescents in 2015.
    Kim HW; Lee S; Kwon D; Cha J; Ahn JG; Kim KH
    J Korean Med Sci; 2017 Jul; 32(7):1111-1117. PubMed ID: 28581267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic.
    Dyet KH; Martin DR
    Epidemiol Infect; 2006 Apr; 134(2):377-83. PubMed ID: 16490143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of invasive serogroup Y meningococci in Italy: prevalence of ST-23 Complex/Cluster A3.
    Fazio C; Neri A; Starnino S; Sofia T; Mastrantonio P; Stefanelli P
    New Microbiol; 2008 Oct; 31(4):467-72. PubMed ID: 19123301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissemination of the ST-103 clonal complex serogroup C meningococci in Salvador, Brazil.
    Cordeiro SM; Cardoso CW; de Araújo LG; Ribeiro LE; Azevedo J; Silva RCV; Dos Reis MG; Ko AI; Reis JN
    Microbes Infect; 2018 Jan; 20(1):19-24. PubMed ID: 28962886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.
    Gilca R; Deceuninck G; Lefebvre B; Tsang R; Amini R; Gilca V; Douville-Fradet M; Markowski F; De Wals P
    PLoS One; 2012; 7(11):e50659. PubMed ID: 23209803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.
    Kugelberg E; Gollan B; Farrance C; Bratcher H; Lucidarme J; Ibarz-Pavón AB; Maiden MC; Borrow R; Tang CM
    PLoS One; 2010 Feb; 5(2):e9413. PubMed ID: 20195528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac.
    Kristiansen PA; Ba AK; Ouédraogo AS; Sanou I; Ouédraogo R; Sangaré L; Diomandé F; Kandolo D; Saga IM; Misegades L; Clark TA; Préziosi MP; Caugant DA
    BMC Infect Dis; 2014 Dec; 14():663. PubMed ID: 25472422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistent occurrence of serogroup Y/sequence type (ST)-23 complex invasive meningococcal disease among patients aged five to 14 years, Italy, 2007 to 2013.
    Fazio C; Neri A; Renna G; Vacca P; Antonetti R; Barbui AM; Daprai L; Lanzafame P; Rossi L; Santino I; Tascini C; Vocale C; Stefanelli P
    Euro Surveill; 2015; 20(45):. PubMed ID: 26606870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
    De Wals P; Deceuninck G; Lefebvre B; Tsang R; Law D; De Serres G; Gilca V; Gilca R; Boulianne N
    Clin Infect Dis; 2017 May; 64(9):1263-1267. PubMed ID: 28207068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.